Aug 17,2022

Vision Loss Rehabilitation Canada Brings Ai-Driven Diabetic Eye Screening to Rural and Indigenous Communities

Vision Loss Rehabilitation Canada Canada’s leading provider of rehabilitation therapy and healthcare services for individuals with vision loss, and Eyenuk, Inc., a global artificial intelligence (AI) medical technology and services company and the leader in real-world applications for AI Eye Screening™ and AI Predictive Biomarkers™, announced the launch of VLRC’s Eye Health Screening Initiative to screen rural, remote and Indigenous populations in Northern and Eastern Ontario for diabetic retinopathy (DR), the leading cause of blindness among working age adults, using Eyenuk’s autonomous AI technology.

COLLABORATION PARTNERSHIP

#institution

#virtual care

View Analyst & Ambassador Comments
Go to original news
Aug 18,2022

Tandem Diabetes Care delivers 1 million insulin boluses using t:connect mobile app

Tandem Diabetes Care announced today that its users have delivered more than 1 million insulin boluses using its app. Users of the t:connect app feature on their mobile devices have reached the 1 million insulin bolus milestone with the t:slim X2 insulin pump within the first month following its commercial release.

PRODUCT

#mobile app

View Analyst & Ambassador Comments
Go to original news
Aug 19,2022

Diabetes Together Conference 2022

The Diabetes Together Conference is being held in Glasgow from the 27th – 30th at the Golden Jubilee Hotel, Glasgow.

CONFERENCES
View Analyst & Ambassador Comments
Go to original news
Aug 19,2022

Global Insulin Patch Pumps Market Report 2022-2026 & 2031 - Integration with Smartphones and Enabling Automation Gaining Traction

The "Insulin Patch Pumps Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering. The global insulin patch pumps market is expected to grow from $1.10 billion in 2021 to $1.18 billion in 2022 at a compound annual growth rate (CAGR) of 7.24%. The insulin patch pumps market is expected to reach $1.63 billion in 2026 at a CAGR of 8.58%.

View Analyst & Ambassador Comments
Go to original news
Aug 22,2022

Insulet Announces FDA Clearance of Omnipod® 5 for Children Aged Two Years and Older with Type 1 Diabetes

Insulet Corporation, the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced it has received clearance from the U.S. Food and Drug Administration (FDA) for its Omnipod® 5 Automated Insulin Delivery System (Omnipod 5) for individuals aged two years and older with type 1 diabetes (T1D). Omnipod 5, the first tubeless automated insulin delivery (AID) system in the U.S., was originally cleared for use in individuals aged six and older in January 2022.

REGULATORY FDA

#insulin pump

View Analyst & Ambassador Comments
Go to original news
Aug 23,2022

Diabetes Care Devices Market Size to hit USD 45.09 Billion by 2028

Diabetes Care Devices Market is valued at USD 26.14 Billion in 2021 and expected to reach USD 45.09 Billion by 2028 with the CAGR of 8.1% over the forecast period. Increasing use of stick free glucose testing, rising prevalence of diabetics, and growing technological advancements are some of the major factors driving the growth of the Global Diabetes Care Devices Market.

View Analyst & Ambassador Comments
Go to original news
Aug 23,2022

POGO Automatic® Blood Glucose Monitoring System for People with Diabetes Introduced in Kroger Health Pharmacies Nationwide

Intuity Medical, Inc., a commercial-stage medical technology and digital health company focused on making life with diabetes easier, today announced that the POGO Automatic® Blood Glucose Monitoring System is now available at the more than 2,200 U.S. pharmacies of Kroger Health, the healthcare division of The Kroger Co. (Read more)

COLLABORATION PARTNERSHIP

#product & service

#bgm

View Analyst & Ambassador Comments
Go to original news
Aug 23,2022

Diabetes Technology Leader and Global Business Executive Doug Lawrence Joins Hygieia as CEO

Hygieia, a digital therapeutics company for insulin therapy, has appointed Doug Lawrence its chief executive officer, responsible for leading operations, development, and global growth of the company and its d-Nav® Insulin Management Program.

View Analyst & Ambassador Comments
Go to original news
Aug 24,2022

LLENA (AI) Health Solutions, Inc. Collaborates with Walmart to Provide Personalized Healthy Grocery Shopping on LLENA (AI) Platform

Digital Diabetes Management Platform LLENA (AI) Health Solutions Inc. is working in cooperation with Walmart to provide personalized grocery recommendations on the LLENA (AI) platform. LLENA (AI) users can now browse and purchase personalized foods from Walmart featured in LLENA (AI)’s Cook it Yourself Module. LLENA (AI)’s proprietary artificial intelligence creates an individualized glycemic index value meal suggestion based on blood sugar, blood pressure, and other preferences. LLENA (AI) users can pick up or receive delivery of Walmart groceries.

COLLABORATION PARTNERSHIP

#product & service

View Analyst & Ambassador Comments
Go to original news
Aug 24,2022

BD to Present at the Wells Fargo 2022 Healthcare Conference

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the Wells Fargo 2022 Healthcare Conference on Wednesday, September 7, 2022 at 12:30pm Eastern Time.

CONFERENCES
View Analyst & Ambassador Comments
Go to original news
Subscribe to DIABETES